Biomerica (NASDAQ:BMRA) Stock Passes Below Two Hundred Day Moving Average of $0.97

Biomerica, Inc. (NASDAQ:BMRAGet Free Report)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.97 and traded as low as $0.70. Biomerica shares last traded at $0.72, with a volume of 59,331 shares trading hands.

Biomerica Stock Down 1.2 %

The company’s fifty day simple moving average is $0.97 and its 200 day simple moving average is $0.96. The stock has a market capitalization of $11.99 million, a price-to-earnings ratio of -1.93 and a beta of -1.04.

Biomerica (NASDAQ:BMRAGet Free Report) last released its quarterly earnings results on Friday, April 12th. The company reported ($0.11) EPS for the quarter. Biomerica had a negative return on equity of 64.00% and a negative net margin of 117.46%. The business had revenue of $1.02 million for the quarter.

Hedge Funds Weigh In On Biomerica

A hedge fund recently raised its stake in Biomerica stock. Russell Investments Group Ltd. increased its holdings in shares of Biomerica, Inc. (NASDAQ:BMRAFree Report) by 15.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 201,563 shares of the company’s stock after acquiring an additional 26,288 shares during the quarter. Russell Investments Group Ltd. owned about 1.20% of Biomerica worth $252,000 as of its most recent filing with the SEC. 22.28% of the stock is owned by hedge funds and other institutional investors.

About Biomerica

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Further Reading

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.